Cancer Cell
Volume 37, Issue 4, 13 April 2020, Pages 530-542
ReviewResponse and Resistance to BCR-ABL1-Targeted Therapies
Under an Elsevier user license
open archive
Keywords
CML
tyrosine kinase inhibitor
targeted therapy
BCR-ABL
Cited by (0)
© 2020 Elsevier Inc.